Frontlight ResearchEarly access
Trial site
Comprehensive Blood and Cancer Center
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Pancreatic cancer2 trials
- Brain metastases1 trial
- Childhood cancers1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Phase
- Phase 13 trials
- Phase 33 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Amgen2 trials
- BriaCell Therapeutics Corporation1 trial
- Eli Lilly and Company1 trial
- Georgiamune Inc1 trial
- HUYABIO International, LLC.1 trial
- and 2 more
Running trials
Active, not recruiting
Active, not recruiting
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Recruiting
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026